Pinnacle Associates’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Sell
1,101
-46
-4% -$12.1K ﹤0.01% 804
2026
Q1
$306K Buy
1,147
+21
+2% +$5.69K ﹤0.01% 795
2025
Q4
$282K Buy
1,126
+42
+4% +$11.2K ﹤0.01% 807
2025
Q3
$311K Buy
1,084
+8
+0.7% +$2.14K ﹤0.01% 741
2025
Q2
$282K Sell
1,076
-121
-10% -$29.5K ﹤0.01% 750
2025
Q1
$279K Buy
1,197
+137
+13% +$33.2K ﹤0.01% 729
2024
Q4
$243K Buy
+1,060
New +$243K ﹤0.01% 768
2024
Q3
Sell
-999
Closed -$203K 828
2024
Q2
$203K Sell
999
-39
-4% -$7.93K ﹤0.01% 775
2024
Q1
$227K Buy
1,038
+17
+2% +$3.75K ﹤0.01% 768
2023
Q4
$232K Buy
+1,021
New +$214K ﹤0.01% 753
2023
Q3
Sell
-1,076
Closed -$223K 823
2023
Q2
$223K Buy
+1,076
New +$209K ﹤0.01% 750

Other funds holding LH

Pinnacle Associates's LH Position: Q2 2026 in Review

Pinnacle Associates reduced its Labcorp (LH) stake by 4% in Q2 2026, selling an estimated $12.1K and leaving 1,101 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #804.

Pinnacle Associates first reported a position in LH in Q2 2023 and has held it in 11 quarters since. The position peaked at $311K in Q3 2025. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Pinnacle Associates held 1,101 shares of Labcorp worth $308K as of Q2 2026.
  • Pinnacle Associates sold 46 Labcorp shares in Q2 2026, an estimated $12.1K.
  • Labcorp made up ﹤0.01% of Pinnacle Associates's portfolio in Q2 2026, its #804 holding.
  • Pinnacle Associates first reported a position in Labcorp in Q2 2023 and has held it in 11 quarters since.
  • Pinnacle Associates's Labcorp position peaked at $311K in Q3 2025.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.